How should Lantus (insulin glargine) and NPH (Neutral Protamine Hagedorn) insulin doses and carb ratio be adjusted for a patient on prednisone with improved fasting blood glucose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adjusting Insulin Regimen for Patient on Prednisone with Improved Fasting Blood Glucose

For this 108 kg, 63-year-old male on prednisone 60 mg with improving fasting blood glucose of 76 mg/dL, reduce Lantus from 20 units to 16 units (20% reduction) and start morning NPH insulin at 30 units (0.3 units/kg) to manage steroid-induced hyperglycemia with a carbohydrate ratio of 1:10.

Lantus Dose Adjustment

  • Reduce the current Lantus dose by 20% (from 20 units to 16 units) due to the improving fasting blood glucose of 76 mg/dL, which indicates risk of hypoglycemia 1
  • The low fasting blood glucose (76 mg/dL) suggests the current Lantus dose may be excessive, especially since Lantus primarily controls fasting/overnight glucose levels 2
  • Lantus has a relatively constant basal level of circulating insulin with no pronounced peak, which makes it less suitable as the sole insulin for managing steroid-induced hyperglycemia 3

NPH Insulin for Steroid-Induced Hyperglycemia

  • Add NPH insulin at 0.3 units/kg (approximately 30 units) to be administered in the morning to match the pharmacokinetic profile of prednisone 4, 5
  • Morning administration of NPH is specifically recommended for steroid-induced hyperglycemia as its peak action (4-6 hours) aligns with the peak hyperglycemic effect of glucocorticoids 4
  • For patients on high-dose glucocorticoids (60 mg prednisone), higher insulin requirements are common, potentially 40-60% more than standard dosing 4, 5

Carbohydrate Ratio and Monitoring

  • Set the carbohydrate ratio at 1:10 to provide adequate insulin coverage for meals, accounting for the insulin resistance caused by high-dose prednisone therapy 5
  • Monitor blood glucose before meals and at bedtime to assess the adequacy of the NPH dose and carbohydrate ratio 5
  • For persistent hyperglycemia, increase the NPH dose by 2 units every 3 days until target blood glucose is achieved without hypoglycemia 1, 4

Special Considerations for This Patient

  • With a high body weight of 108 kg, this patient likely has baseline insulin resistance requiring higher insulin doses 5
  • The combination of Lantus and NPH provides better 24-hour coverage: NPH for daytime steroid-induced hyperglycemia and reduced Lantus for overnight control 6
  • If hypoglycemia occurs, determine the cause and if no clear reason is found, lower the corresponding insulin dose by 10-20% 1, 4

Adjustments During Steroid Taper

  • When prednisone dose is reduced, decrease the NPH dose by 10-20% to prevent hypoglycemia 4
  • Focus primarily on reducing the morning NPH dose when tapering morning steroids 4
  • Consider switching from NPH back to Lantus-only regimen after complete steroid discontinuation if the patient has frequent hypoglycemia 4

Common Pitfalls to Avoid

  • Avoid relying solely on Lantus for steroid-induced hyperglycemia management, as its flat profile doesn't match the daytime hyperglycemic pattern of steroids 4, 6
  • Don't underestimate insulin requirements in patients on high-dose steroids; inadequate dosing leads to persistent hyperglycemia 4, 5
  • Be vigilant for nocturnal hypoglycemia with the combined insulin regimen, especially with the improving fasting glucose 2, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Insulin glargine (Lantus).

International journal of clinical practice, 2002

Guideline

Management of Steroid-Induced Hyperglycemia with NPH Insulin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Steroid-Induced Hyperglycemia with NPH Insulin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.